Low incidence of adverse events following 90‐minute and 3‐minute infusions of intravenous iron sucrose in children on erythropoietin
Authors:
- 1 December 2005
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 94 (12) , 1738-1741
Abstract
Aim: To define the adverse events following two different rates and methods of intravenous iron sucrose infusions in children with anaemia due to chronic renal impairment. Methods: Two prospective observational studies were undertaken to characterize the adverse events following iron sucrose administration in children with renal impairment and on erythropoietin. Between January 1999 and April 2003, 5 mg/kg of intravenous (IV) iron sucrose was given over 90 min and repeated 24 h later. Between May 2003 and September 2004, in children with better venous access, a single dose of 2 mg/kg of IV iron sucrose was administered over 3 min during an outpatient clinic visit and haemodialysis sessions. Following infusions, children were monitored for immediate and delayed adverse events. All such events were documented and dealt with appropriately. Test doses were not used. Results: A total of 870 infusions over 90 min were administered to 72 children. Three children developed abdominal pain. One child developed worsening of hypertension (not related to iron sucrose). Sixty‐five doses were administered over 3 min to 20 children, and six minor adverse events were documented. Conclusion: Although 90 min infusion is associated with fewer adverse events, no life‐threatening events were documented in either method.Keywords
This publication has 9 references indexed in Scilit:
- Intravenous iron sucrose: Establishing a safe doseAmerican Journal of Kidney Diseases, 2001
- A randomized, controlled parallel‐group trial on efficacy and safety of iron sucrose (Venofer®) vs iron gluconate (Ferrlecit®) in haemodialysis patients treated with rHuEpoNephrology Dialysis Transplantation, 2001
- Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trialAmerican Journal of Kidney Diseases, 2000
- Intravenous iron treatment of renal anemia in children on hemodialysisPediatric Nephrology, 1999
- Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextransAmerican Journal of Kidney Diseases, 1999
- Strategies for iron supplementation: Oral versus intravenousKidney International, 1999
- A randomized controlled study of iron supplementation in patients treated with erythropoietinKidney International, 1996
- The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1996
- Iron Deficiency in Maintenance Hemodialysis Patients: Assessment of Diagnosis Criteria and of Three Different Iron TreatmentsNephron, 1991